Physicool is used within the NHS, private hospitals and by healthcare professionals across the UK as an effective way to reduce pain, swelling and inflammation across a wide range of applications.
“We are always looking for new ways to improve patient aftercare. Physicool reduces patient’s pain and gets them back home quicker. Physicool not only mobilises patients quicker than Cryocuff, it is also a third of the cost.”
Dr. Simon Garrett, Consultant Trauma & Orthopaedic Surgeon, Dorchester County Hospital NHS Trust
Integrated cold and compression has been clinically proven to help reduce swelling and help the affected person regain their range of movement. The reservoir fuelled cryotherapy cuffs superseded the results of ice, which has led to many surgeons and therapists choosing Physicool as their preferred way of cooling an injury.
Physicool was initially used post-surgery on patients on patients who has undergone knee replacement surgery. When placed on an affected area, the Coolant (comprised of rapidly evaporating alcohols) evaporates, absorbing latent heat which reduces swelling and pain, and aiding the healing process. Thanks to the bandage being manufactured using an open-cell weave, the bandage provides 2 to 3 hours of cooling before needing a recharge.
After the initial success achieved post-total knee arthroplasty (Garrett, 2012), Physicool is now being used as a way on enhancing patient rehabilitation across all body parts post-operatively, joint inflammation, traumas, rheumatoid arthritis and haematomas, as well as to help the recovery process of many sporting injuries.
Physicool has proven to outperform existing cold therapies, without the associated risk that comes with ice-based therapies. In 2012 Mr A. Mumith MRCS, Mr M Barrett MRCS and Mr S. Garrett FRCS (Tr&Orth) conducted an Ethics approved, non-commercial study to compare the efficacy of Physicool with the Cryo Cuff cooling system in Total Knee Arthroplastry (TKA) patients. The method used a random study by patient hospital number of 80 patients – 40 per group. All TKAs were by a single surgeon using default surgical techniques.
The cooling devices were assigned on the first day post-operation, with VAS pain scores and the range of movement recorded pre-cooling and 30 minutes following cooling. Results were recorded for the first and second days following the operation, after which the patients were discharged.
Dorset NHS Hospital Range of Movement Trial Using Physicool
The trial which took place at Dorset NHS Hospital in the UK found that Physicool is a very viable alternative to Cryo/Cuff. For the Physicool group, there was a statistically significant increase in the range of motion and the decrease in pain compared to those in the Cryo/Cuff group.
On the first day post operation, those in the Physicool group had a 20.38° improvement in range of motion, which was 65% greater than that achieved by the Cryo/Cuff group. The VAS pain score was also reduced by 44% more than was achieved by the Cryo/Cuff group.
On the second day post operation, those in the Physicool group had an improvement in range of motion, 83% greater than that achieved by the Cryo/Cuff group. The VAS pain score in the Physicool group was also reduced by 116% compared to the reduction in the Cryo/Cuff group.
Although there was circumstantial evidence of the Physicool group continuing to outperform the Cryo/Cuff group after the patients were discharged, the improvement could not be quantified as part of this first study.
For the purposes of the study, both groups were limited to two 30-minute cool sessions per day. In normal use, Physicool has an important advantage over Cryo/Cuff treatment as it can be used for significantly longer periods. This is because Physicool does not restrict ambulatory movement, the bandage can be left on and will cool for up to two hours before all the coolant has evaporated, and the coolant can then be recharged using the spray.
There is a belief that in normal clinical use, both before and after discharge, patients will be willing to use Physicool more frequently and for longer periods than they would consider using Cyro/Cuff. Thus, their improvements in pain relief and range of motion are likely to be even greater than was achieved in this controlled study.